available for iOS, Android & web
September 26, 2013
Oncotype DX to help make decisions on chemotherapy
July 02, 2013
A greater number of patients with breast cancer could be spared chemotherapy to reduce their risk of the disease returning, after UK scientists developed a more accurate genetic test to determine the likelihood of recurrence.
February 19, 2013
New draft guidance from NICE recommends that the NHS should use one test, Oncotype DX, to guide decisions about the use of chemotherapy in people with early breast cancer, but not three others.
PharmaTimes 2014 Copyright | RSS Feed Subscriptions